HEADER TRANSFERASE 22-APR-13 4KAT TITLE CRYSTAL STRUCTURE OF FDTS FROM T. MARITIMA MUTANT (R174K) WITH FAD AND TITLE 2 DUMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: TM0449 (UNP RESIDUES 1-220); COMPND 5 SYNONYM: TS, TSASE; COMPND 6 EC: 2.1.1.148; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: THERMOTOGA MARITIMA MSB8; SOURCE 3 ORGANISM_TAXID: 243274; SOURCE 4 STRAIN: ATCC 43589 / MSB8 / DSM 3109 / JCM 10099; SOURCE 5 GENE: THY1, THYX, TM0449, TM_0449; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PMH1 KEYWDS THYX, FDTS, FAD, DUMP, NOVEL FDTS FOLD, CONVERTION OF DUMP TO DTMP KEYWDS 2 USING TETRAHYDROFOLATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR I.I.MATHEWS REVDAT 2 20-SEP-23 4KAT 1 REMARK SEQADV REVDAT 1 26-MAR-14 4KAT 0 JRNL AUTH I.I.MATHEWS JRNL TITL FLAVIN-DEPENDENT THYMIDYLATE SYNTHASE AS A DRUG TARGET FOR JRNL TITL 2 DEADLY MICROBES: MUTATIONAL STUDY AND A STRATEGY FOR JRNL TITL 3 INHIBITOR DESIGN. JRNL REF J BIOTERROR BIODEF V.L 12 004 2013 JRNL REFN ESSN 2157-2526 JRNL PMID 24563811 JRNL DOI 10.4172/2157-2526.S12-004 REMARK 2 REMARK 2 RESOLUTION. 2.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 46655 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2457 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.14 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.20 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3349 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.83 REMARK 3 BIN R VALUE (WORKING SET) : 0.2780 REMARK 3 BIN FREE R VALUE SET COUNT : 176 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7203 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 292 REMARK 3 SOLVENT ATOMS : 103 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.09000 REMARK 3 B22 (A**2) : -0.58000 REMARK 3 B33 (A**2) : -3.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.272 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.205 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.153 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.984 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.964 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7724 ; 0.013 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10494 ; 1.716 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 855 ; 6.434 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 372 ;33.743 ;22.473 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1307 ;16.307 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 65 ;20.131 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1107 ; 0.114 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5788 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4KAT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-APR-13. REMARK 100 THE DEPOSITION ID IS D_1000079107. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUN-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS PACKAGE REMARK 200 DATA SCALING SOFTWARE : XDS PACKAGE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49181 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.140 REMARK 200 RESOLUTION RANGE LOW (A) : 38.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.07300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.70 REMARK 200 R MERGE FOR SHELL (I) : 0.88500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.210 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 1O26 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.99 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 - 60% PEG200, 0.1TRIS.HCL, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 295K, PH 8.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.84000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 70.23000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 57.87000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 70.23000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.84000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 57.87000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE DEPOSITED COORDINATE REPRESENTS THE BIOLOGICAL TETRAMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 23190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 31520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -60.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -11 REMARK 465 GLY A -10 REMARK 465 SER A -9 REMARK 465 ASP A -8 REMARK 465 LYS A -7 REMARK 465 ILE A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 GLU A 217 REMARK 465 VAL A 218 REMARK 465 GLN A 219 REMARK 465 VAL A 220 REMARK 465 MET B -11 REMARK 465 GLY B -10 REMARK 465 SER B -9 REMARK 465 ASP B -8 REMARK 465 LYS B -7 REMARK 465 ILE B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 VAL B 220 REMARK 465 MET C -11 REMARK 465 GLY C -10 REMARK 465 SER C -9 REMARK 465 ASP C -8 REMARK 465 LYS C -7 REMARK 465 ILE C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 HIS C -1 REMARK 465 HIS C 0 REMARK 465 PHE C 31 REMARK 465 ASP C 32 REMARK 465 MET C 33 REMARK 465 GLY C 34 REMARK 465 LEU C 35 REMARK 465 GLN C 219 REMARK 465 VAL C 220 REMARK 465 MET D -11 REMARK 465 GLY D -10 REMARK 465 SER D -9 REMARK 465 ASP D -8 REMARK 465 LYS D -7 REMARK 465 ILE D -6 REMARK 465 HIS D -5 REMARK 465 HIS D -4 REMARK 465 HIS D -3 REMARK 465 HIS D -2 REMARK 465 HIS D -1 REMARK 465 ASP D 32 REMARK 465 MET D 33 REMARK 465 GLY D 34 REMARK 465 LEU D 35 REMARK 465 LYS D 36 REMARK 465 ASP D 37 REMARK 465 SER D 92 REMARK 465 LYS D 93 REMARK 465 LEU D 94 REMARK 465 SER D 95 REMARK 465 GLN D 219 REMARK 465 VAL D 220 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS D 0 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 6 -158.58 54.25 REMARK 500 ASN A 19 -169.59 -162.75 REMARK 500 LYS A 36 -109.70 -108.08 REMARK 500 LEU A 87 132.10 -34.80 REMARK 500 ALA A 209 -32.70 -132.92 REMARK 500 LEU B 6 -153.57 51.12 REMARK 500 LYS B 36 -87.36 -113.57 REMARK 500 GLU B 38 -71.09 -35.05 REMARK 500 LEU C 6 -144.33 59.65 REMARK 500 TYR C 96 66.23 -69.57 REMARK 500 LEU D 6 -151.69 60.42 REMARK 500 ASN D 19 -166.19 -160.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER C 88 GLY C 89 38.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DU A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DU B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DU C 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE FDA D 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DU D 302 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4KAR RELATED DB: PDB REMARK 900 RELATED ID: 4KAS RELATED DB: PDB DBREF 4KAT A 1 220 UNP Q9WYT0 THYX_THEMA 1 220 DBREF 4KAT B 1 220 UNP Q9WYT0 THYX_THEMA 1 220 DBREF 4KAT C 1 220 UNP Q9WYT0 THYX_THEMA 1 220 DBREF 4KAT D 1 220 UNP Q9WYT0 THYX_THEMA 1 220 SEQADV 4KAT MET A -11 UNP Q9WYT0 INITIATING METHIONINE SEQADV 4KAT GLY A -10 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT SER A -9 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ASP A -8 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS A -7 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ILE A -6 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A -5 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A -4 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A -3 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A -2 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A -1 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS A 0 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS A 174 UNP Q9WYT0 ARG 174 ENGINEERED MUTATION SEQADV 4KAT MET B -11 UNP Q9WYT0 INITIATING METHIONINE SEQADV 4KAT GLY B -10 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT SER B -9 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ASP B -8 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS B -7 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ILE B -6 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B -5 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B -4 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B -3 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B -2 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B -1 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS B 0 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS B 174 UNP Q9WYT0 ARG 174 ENGINEERED MUTATION SEQADV 4KAT MET C -11 UNP Q9WYT0 INITIATING METHIONINE SEQADV 4KAT GLY C -10 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT SER C -9 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ASP C -8 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS C -7 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ILE C -6 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C -5 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C -4 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C -3 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C -2 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C -1 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS C 0 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS C 174 UNP Q9WYT0 ARG 174 ENGINEERED MUTATION SEQADV 4KAT MET D -11 UNP Q9WYT0 INITIATING METHIONINE SEQADV 4KAT GLY D -10 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT SER D -9 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ASP D -8 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS D -7 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT ILE D -6 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D -5 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D -4 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D -3 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D -2 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D -1 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT HIS D 0 UNP Q9WYT0 EXPRESSION TAG SEQADV 4KAT LYS D 174 UNP Q9WYT0 ARG 174 ENGINEERED MUTATION SEQRES 1 A 232 MET GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS MET SEQRES 2 A 232 LYS ILE ASP ILE LEU ASP LYS GLY PHE VAL GLU LEU VAL SEQRES 3 A 232 ASP VAL MET GLY ASN ASP LEU SER ALA VAL ARG ALA ALA SEQRES 4 A 232 ARG VAL SER PHE ASP MET GLY LEU LYS ASP GLU GLU ARG SEQRES 5 A 232 ASP ARG HIS LEU ILE GLU TYR LEU MET LYS HIS GLY HIS SEQRES 6 A 232 GLU THR PRO PHE GLU HIS ILE VAL PHE THR PHE HIS VAL SEQRES 7 A 232 LYS ALA PRO ILE PHE VAL ALA ARG GLN TRP PHE ARG HIS SEQRES 8 A 232 ARG ILE ALA SER TYR ASN GLU LEU SER GLY ARG TYR SER SEQRES 9 A 232 LYS LEU SER TYR GLU PHE TYR ILE PRO SER PRO GLU ARG SEQRES 10 A 232 LEU GLU GLY TYR LYS THR THR ILE PRO PRO GLU ARG VAL SEQRES 11 A 232 THR GLU LYS ILE SER GLU ILE VAL ASP LYS ALA TYR ARG SEQRES 12 A 232 THR TYR LEU GLU LEU ILE GLU SER GLY VAL PRO ARG GLU SEQRES 13 A 232 VAL ALA ARG ILE VAL LEU PRO LEU ASN LEU TYR THR ARG SEQRES 14 A 232 PHE PHE TRP THR VAL ASN ALA ARG SER LEU MET ASN PHE SEQRES 15 A 232 LEU ASN LEU LYS ALA ASP SER HIS ALA GLN TRP GLU ILE SEQRES 16 A 232 GLN GLN TYR ALA LEU ALA ILE ALA ARG ILE PHE LYS GLU SEQRES 17 A 232 LYS CYS PRO TRP THR PHE GLU ALA PHE LEU LYS TYR ALA SEQRES 18 A 232 TYR LYS GLY ASP ILE LEU LYS GLU VAL GLN VAL SEQRES 1 B 232 MET GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS MET SEQRES 2 B 232 LYS ILE ASP ILE LEU ASP LYS GLY PHE VAL GLU LEU VAL SEQRES 3 B 232 ASP VAL MET GLY ASN ASP LEU SER ALA VAL ARG ALA ALA SEQRES 4 B 232 ARG VAL SER PHE ASP MET GLY LEU LYS ASP GLU GLU ARG SEQRES 5 B 232 ASP ARG HIS LEU ILE GLU TYR LEU MET LYS HIS GLY HIS SEQRES 6 B 232 GLU THR PRO PHE GLU HIS ILE VAL PHE THR PHE HIS VAL SEQRES 7 B 232 LYS ALA PRO ILE PHE VAL ALA ARG GLN TRP PHE ARG HIS SEQRES 8 B 232 ARG ILE ALA SER TYR ASN GLU LEU SER GLY ARG TYR SER SEQRES 9 B 232 LYS LEU SER TYR GLU PHE TYR ILE PRO SER PRO GLU ARG SEQRES 10 B 232 LEU GLU GLY TYR LYS THR THR ILE PRO PRO GLU ARG VAL SEQRES 11 B 232 THR GLU LYS ILE SER GLU ILE VAL ASP LYS ALA TYR ARG SEQRES 12 B 232 THR TYR LEU GLU LEU ILE GLU SER GLY VAL PRO ARG GLU SEQRES 13 B 232 VAL ALA ARG ILE VAL LEU PRO LEU ASN LEU TYR THR ARG SEQRES 14 B 232 PHE PHE TRP THR VAL ASN ALA ARG SER LEU MET ASN PHE SEQRES 15 B 232 LEU ASN LEU LYS ALA ASP SER HIS ALA GLN TRP GLU ILE SEQRES 16 B 232 GLN GLN TYR ALA LEU ALA ILE ALA ARG ILE PHE LYS GLU SEQRES 17 B 232 LYS CYS PRO TRP THR PHE GLU ALA PHE LEU LYS TYR ALA SEQRES 18 B 232 TYR LYS GLY ASP ILE LEU LYS GLU VAL GLN VAL SEQRES 1 C 232 MET GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS MET SEQRES 2 C 232 LYS ILE ASP ILE LEU ASP LYS GLY PHE VAL GLU LEU VAL SEQRES 3 C 232 ASP VAL MET GLY ASN ASP LEU SER ALA VAL ARG ALA ALA SEQRES 4 C 232 ARG VAL SER PHE ASP MET GLY LEU LYS ASP GLU GLU ARG SEQRES 5 C 232 ASP ARG HIS LEU ILE GLU TYR LEU MET LYS HIS GLY HIS SEQRES 6 C 232 GLU THR PRO PHE GLU HIS ILE VAL PHE THR PHE HIS VAL SEQRES 7 C 232 LYS ALA PRO ILE PHE VAL ALA ARG GLN TRP PHE ARG HIS SEQRES 8 C 232 ARG ILE ALA SER TYR ASN GLU LEU SER GLY ARG TYR SER SEQRES 9 C 232 LYS LEU SER TYR GLU PHE TYR ILE PRO SER PRO GLU ARG SEQRES 10 C 232 LEU GLU GLY TYR LYS THR THR ILE PRO PRO GLU ARG VAL SEQRES 11 C 232 THR GLU LYS ILE SER GLU ILE VAL ASP LYS ALA TYR ARG SEQRES 12 C 232 THR TYR LEU GLU LEU ILE GLU SER GLY VAL PRO ARG GLU SEQRES 13 C 232 VAL ALA ARG ILE VAL LEU PRO LEU ASN LEU TYR THR ARG SEQRES 14 C 232 PHE PHE TRP THR VAL ASN ALA ARG SER LEU MET ASN PHE SEQRES 15 C 232 LEU ASN LEU LYS ALA ASP SER HIS ALA GLN TRP GLU ILE SEQRES 16 C 232 GLN GLN TYR ALA LEU ALA ILE ALA ARG ILE PHE LYS GLU SEQRES 17 C 232 LYS CYS PRO TRP THR PHE GLU ALA PHE LEU LYS TYR ALA SEQRES 18 C 232 TYR LYS GLY ASP ILE LEU LYS GLU VAL GLN VAL SEQRES 1 D 232 MET GLY SER ASP LYS ILE HIS HIS HIS HIS HIS HIS MET SEQRES 2 D 232 LYS ILE ASP ILE LEU ASP LYS GLY PHE VAL GLU LEU VAL SEQRES 3 D 232 ASP VAL MET GLY ASN ASP LEU SER ALA VAL ARG ALA ALA SEQRES 4 D 232 ARG VAL SER PHE ASP MET GLY LEU LYS ASP GLU GLU ARG SEQRES 5 D 232 ASP ARG HIS LEU ILE GLU TYR LEU MET LYS HIS GLY HIS SEQRES 6 D 232 GLU THR PRO PHE GLU HIS ILE VAL PHE THR PHE HIS VAL SEQRES 7 D 232 LYS ALA PRO ILE PHE VAL ALA ARG GLN TRP PHE ARG HIS SEQRES 8 D 232 ARG ILE ALA SER TYR ASN GLU LEU SER GLY ARG TYR SER SEQRES 9 D 232 LYS LEU SER TYR GLU PHE TYR ILE PRO SER PRO GLU ARG SEQRES 10 D 232 LEU GLU GLY TYR LYS THR THR ILE PRO PRO GLU ARG VAL SEQRES 11 D 232 THR GLU LYS ILE SER GLU ILE VAL ASP LYS ALA TYR ARG SEQRES 12 D 232 THR TYR LEU GLU LEU ILE GLU SER GLY VAL PRO ARG GLU SEQRES 13 D 232 VAL ALA ARG ILE VAL LEU PRO LEU ASN LEU TYR THR ARG SEQRES 14 D 232 PHE PHE TRP THR VAL ASN ALA ARG SER LEU MET ASN PHE SEQRES 15 D 232 LEU ASN LEU LYS ALA ASP SER HIS ALA GLN TRP GLU ILE SEQRES 16 D 232 GLN GLN TYR ALA LEU ALA ILE ALA ARG ILE PHE LYS GLU SEQRES 17 D 232 LYS CYS PRO TRP THR PHE GLU ALA PHE LEU LYS TYR ALA SEQRES 18 D 232 TYR LYS GLY ASP ILE LEU LYS GLU VAL GLN VAL HET DU A 301 20 HET FDA A 302 53 HET DU B 301 20 HET FDA B 302 53 HET FDA C 301 53 HET DU C 302 20 HET FDA D 301 53 HET DU D 302 20 HETNAM DU 2'-DEOXYURIDINE-5'-MONOPHOSPHATE HETNAM FDA DIHYDROFLAVINE-ADENINE DINUCLEOTIDE FORMUL 5 DU 4(C9 H13 N2 O8 P) FORMUL 6 FDA 4(C27 H35 N9 O15 P2) FORMUL 13 HOH *103(H2 O) HELIX 1 1 ASN A 19 VAL A 29 1 11 HELIX 2 2 SER A 30 ASP A 32 5 3 HELIX 3 3 ASP A 37 HIS A 51 1 15 HELIX 4 4 GLU A 54 HIS A 59 5 6 HELIX 5 5 ILE A 70 PHE A 77 1 8 HELIX 6 6 SER A 102 GLU A 107 5 6 HELIX 7 7 PRO A 114 SER A 139 1 26 HELIX 8 8 PRO A 142 ARG A 147 1 6 HELIX 9 9 ILE A 148 LEU A 150 5 3 HELIX 10 10 ALA A 164 ALA A 175 1 12 HELIX 11 11 GLN A 180 CYS A 198 1 19 HELIX 12 12 CYS A 198 ALA A 209 1 12 HELIX 13 13 ASN B 19 VAL B 29 1 11 HELIX 14 14 SER B 30 ASP B 32 5 3 HELIX 15 15 ASP B 37 HIS B 51 1 15 HELIX 16 16 GLU B 54 HIS B 59 5 6 HELIX 17 17 ILE B 70 PHE B 77 1 8 HELIX 18 18 SER B 102 LEU B 106 5 5 HELIX 19 19 PRO B 114 SER B 139 1 26 HELIX 20 20 PRO B 142 ARG B 147 1 6 HELIX 21 21 ILE B 148 LEU B 150 5 3 HELIX 22 22 ALA B 164 ALA B 175 1 12 HELIX 23 23 GLN B 180 CYS B 198 1 19 HELIX 24 24 CYS B 198 ALA B 209 1 12 HELIX 25 25 ASP B 213 GLU B 217 5 5 HELIX 26 26 ASN C 19 VAL C 29 1 11 HELIX 27 27 ASP C 37 HIS C 51 1 15 HELIX 28 28 GLU C 54 HIS C 59 5 6 HELIX 29 29 ILE C 70 PHE C 77 1 8 HELIX 30 30 SER C 102 LEU C 106 5 5 HELIX 31 31 PRO C 114 SER C 139 1 26 HELIX 32 32 PRO C 142 ARG C 147 1 6 HELIX 33 33 ILE C 148 LEU C 150 5 3 HELIX 34 34 ALA C 164 ALA C 175 1 12 HELIX 35 35 GLN C 180 CYS C 198 1 19 HELIX 36 36 CYS C 198 ALA C 209 1 12 HELIX 37 37 ASN D 19 VAL D 29 1 11 HELIX 38 38 GLU D 39 HIS D 51 1 13 HELIX 39 39 GLU D 54 HIS D 59 5 6 HELIX 40 40 ILE D 70 PHE D 77 1 8 HELIX 41 41 SER D 102 GLU D 107 5 6 HELIX 42 42 PRO D 114 SER D 139 1 26 HELIX 43 43 PRO D 142 ARG D 147 1 6 HELIX 44 44 ILE D 148 LEU D 150 5 3 HELIX 45 45 ALA D 164 ALA D 175 1 12 HELIX 46 46 GLN D 180 CYS D 198 1 19 HELIX 47 47 CYS D 198 ALA D 209 1 12 HELIX 48 48 ASP D 213 VAL D 218 1 6 SHEET 1 A 5 MET A 1 ILE A 5 0 SHEET 2 A 5 GLY A 9 MET A 17 -1 O VAL A 11 N ILE A 3 SHEET 3 A 5 VAL A 61 PRO A 69 -1 O VAL A 61 N MET A 17 SHEET 4 A 5 TYR A 155 ASN A 163 -1 O THR A 156 N ALA A 68 SHEET 5 A 5 SER A 83 GLU A 86 -1 N ASN A 85 O PHE A 159 SHEET 1 B 5 LYS B 2 ILE B 5 0 SHEET 2 B 5 GLY B 9 MET B 17 -1 O VAL B 11 N ILE B 3 SHEET 3 B 5 VAL B 61 PRO B 69 -1 O THR B 63 N VAL B 14 SHEET 4 B 5 TYR B 155 ASN B 163 -1 O THR B 156 N ALA B 68 SHEET 5 B 5 SER B 83 GLU B 86 -1 N SER B 83 O THR B 161 SHEET 1 C 5 LYS C 2 ILE C 5 0 SHEET 2 C 5 GLY C 9 MET C 17 -1 O VAL C 11 N ILE C 3 SHEET 3 C 5 VAL C 61 PRO C 69 -1 O THR C 63 N VAL C 14 SHEET 4 C 5 TYR C 155 ASN C 163 -1 O TRP C 160 N PHE C 64 SHEET 5 C 5 SER C 83 GLU C 86 -1 N SER C 83 O THR C 161 SHEET 1 D 5 MET D 1 ILE D 5 0 SHEET 2 D 5 GLY D 9 MET D 17 -1 O VAL D 11 N ILE D 3 SHEET 3 D 5 VAL D 61 PRO D 69 -1 O VAL D 61 N MET D 17 SHEET 4 D 5 TYR D 155 ASN D 163 -1 O THR D 156 N ALA D 68 SHEET 5 D 5 SER D 83 GLU D 86 -1 N SER D 83 O THR D 161 SITE 1 AC1 12 GLU A 86 LEU A 87 SER A 88 GLY A 89 SITE 2 AC1 12 ARG A 90 ARG A 147 HOH A 409 HOH A 426 SITE 3 AC1 12 ARG D 74 GLN D 75 ARG D 78 FDA D 301 SITE 1 AC2 18 ARG A 78 HIS A 79 ARG A 80 ILE A 81 SITE 2 AC2 18 ASN A 169 LEU A 173 LYS A 174 HIS A 178 SITE 3 AC2 18 THR C 55 GLU C 58 ILE C 81 ASN C 163 SITE 4 AC2 18 ARG C 165 FDA C 301 ASN D 85 GLU D 86 SITE 5 AC2 18 SER D 88 DU D 302 SITE 1 AC3 10 GLU B 86 LEU B 87 SER B 88 GLY B 89 SITE 2 AC3 10 ARG B 90 ARG B 147 GLN C 75 ARG C 78 SITE 3 AC3 10 FDA C 301 HOH C 402 SITE 1 AC4 20 ARG B 78 HIS B 79 ARG B 80 ILE B 81 SITE 2 AC4 20 ASN B 169 LEU B 173 HIS B 178 ALA B 179 SITE 3 AC4 20 HOH B 413 ASN C 85 GLU C 86 SER C 88 SITE 4 AC4 20 DU C 302 HOH C 401 THR D 55 GLU D 58 SITE 5 AC4 20 ILE D 81 ASN D 163 ARG D 165 FDA D 301 SITE 1 AC5 21 SER A 30 THR A 55 GLU A 58 ILE A 81 SITE 2 AC5 21 ASN A 163 ARG A 165 FDA A 302 ASN B 85 SITE 3 AC5 21 GLU B 86 SER B 88 TYR B 91 DU B 301 SITE 4 AC5 21 ARG C 78 HIS C 79 ARG C 80 ILE C 81 SITE 5 AC5 21 ASN C 169 LEU C 173 HIS C 178 ALA C 179 SITE 6 AC5 21 HOH C 414 SITE 1 AC6 12 GLN B 75 ARG B 78 LYS B 174 FDA B 302 SITE 2 AC6 12 GLU C 86 LEU C 87 SER C 88 GLY C 89 SITE 3 AC6 12 ARG C 90 ARG C 147 HOH C 406 HOH C 431 SITE 1 AC7 20 ASN A 85 GLU A 86 SER A 88 DU A 301 SITE 2 AC7 20 SER B 30 THR B 55 GLU B 58 ILE B 81 SITE 3 AC7 20 ASN B 163 ARG B 165 FDA B 302 ARG D 78 SITE 4 AC7 20 HIS D 79 ARG D 80 ILE D 81 ASN D 169 SITE 5 AC7 20 LEU D 173 HIS D 178 HOH D 412 HOH D 419 SITE 1 AC8 12 GLN A 75 ARG A 78 LYS A 174 FDA A 302 SITE 2 AC8 12 HOH A 417 GLU D 86 LEU D 87 SER D 88 SITE 3 AC8 12 GLY D 89 ARG D 90 ARG D 147 HOH D 402 CRYST1 53.680 115.740 140.460 90.00 90.00 90.00 P 21 21 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018629 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008640 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007119 0.00000